1. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31:143–178.
Article
2. Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol. 2007; 119:1043–1052.
Article
3. Horn BR, Robin ED, Theodore J, Van Kessel A. Total eosinophil counts in the management of bronchial asthma. N Engl J Med. 1975; 292:1152–1155.
Article
4. Louis R, Sele J, Henket M, Cataldo D, Bettiol J, Seiden L, et al. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy. 2002; 57:907–912.
Article
5. Wegmann M. Targeting eosinophil biology in asthma therapy. Am J Respir Cell Mol Biol. 2011; 45:667–674.
Article
6. Kim CK, Koh YY, Callaway Z. The validity of induced sputum and bronchoalveolar lavage in childhood asthma. J Asthma. 2009; 46:105–112.
Article
7. Handoyo S, Rosenwasser LJ. Asthma phenotypes. Curr Allergy Asthma Rep. 2009; 9:439–445.
Article
8. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006; 11:54–61.
Article
9. Jensen ME, Wood LG, Gibson PG. Obesity and childhood asthma - mechanisms and manifestations. Curr Opin Allergy Clin Immunol. 2012; 12:186–192.
Article
10. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002; 57:643–648.
Article
11. Kim KW, Lee KE, Kim ES, Song TW, Sohn MH, Kim KE. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma. Lung. 2007; 185:97–103.
Article
12. Pizzichini E, Pizzichini MM, Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol. 1997; 99:539–544.
Article
13. Simon D, Braathen LR, Simon HU. Anti-interleukin-5 antibody therapy in eosinophilic diseases. Pathobiology. 2005; 72:287–292.
Article
14. Garcia G, Taille C, Laveneziana P, Bourdin A, Chanez P, Humbert M. Anti-interleukin-5 therapy in severe asthma. Eur Respir Rev. 2013; 22:251–257.
Article
15. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000; 161:309–329.
16. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005; 26:319–338.
Article
17. Komarow HD, Myles IA, Uzzaman A, Metcalfe DD. Impulse oscillometry in the evaluation of diseases of the airways in children. Ann Allergy Asthma Immunol. 2011; 106:191–199.
Article
18. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P, et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med. 2007; 175:1304–1345.
Article
19. Kim YH, Kim KW, Baek J, Park HB, Kim H, Song KJ, et al. Usefulness of impulse oscillometry and fractional exhaled nitric oxide in children with Eosinophilic bronchitis. Pediatr Pulmonol. 2013; 48:221–228.
Article
20. Yoshikawa T, Shoji S, Fujii T, Kanazawa H, Kudoh S, Hirata K, et al. Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur Respir J. 1998; 12:879–884.
Article
21. Nadif R, Siroux V, Oryszczyn MP, Ravault C, Pison C, Pin I, et al. Heterogeneity of asthma according to blood inflammatory patterns. Thorax. 2009; 64:374–380.
Article
22. Butnariu A, Giurgiui D. Clinical pictures of bronchial asthma in children. Pneumologia. 2005; 54:104–107.
23. Bousquet J, Chanez P, Vignola AM, Lacoste JY, Michel FB. Eosinophil inflammation in asthma. Am J Respir Crit Care Med. 1994; 150(5 Pt 2):S33–S38.
Article
24. Fahy JV. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc. 2009; 6:256–259.
Article
25. Kilic H, Karalezli A, Hasanoglu HC, Erel O, Ates C. The relationship between hs-CRP and asthma control test in asthmatic patients. Allergol Immunopathol (Madr). 2012; 40:362–367.
Article
26. Foster PS. Allergic networks regulating eosinophilia. Am J Respir Cell Mol Biol. 1999; 21:451–454.
Article
27. Kabesch M, Depner M, Dahmen I, Weiland SK, Vogelberg C, Niggemann B, et al. Polymorphisms in eosinophil pathway genes, asthma and atopy. Allergy. 2007; 62:423–428.
28. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol. 2000; 105:651–663.
Article
29. Lee WJ, Choi IS, Jeong JW, Lee SR. Clinical significance of blood eosinophilia and neutrophilia in patients with acute asthma. Korean J Asthma Allergy Clin Immunol. 2008; 28:184–191.
30. Panzer SE, Dodge AM, Kelly EA, Jarjour NN. Circadian variation of sputum inflammatory cells in mild asthma. J Allergy Clin Immunol. 2003; 111:308–312.
Article
31. Davidson WJ, Wong LE, The S, Leigh R. The impact of diurnal variation on induced sputum cell counts in healthy adults. Clin Transl Allergy. 2013; 3:8.
Article